Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 21 | 2025 | 302 | 4.500 |
Why?
|
| Nicotinic Agonists | 7 | 2025 | 88 | 1.900 |
Why?
|
| Receptors, Nicotinic | 5 | 2020 | 114 | 1.420 |
Why?
|
| Aerosols | 7 | 2025 | 54 | 1.220 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 42 | 1.150 |
Why?
|
| Respiratory Center | 7 | 2020 | 11 | 1.030 |
Why?
|
| Seizures | 2 | 2020 | 79 | 0.750 |
Why?
|
| Respiration | 3 | 2019 | 56 | 0.720 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2024 | 192 | 0.670 |
Why?
|
| Animals | 39 | 2026 | 16992 | 0.640 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 15 | 0.640 |
Why?
|
| Behavior, Animal | 2 | 2020 | 373 | 0.640 |
Why?
|
| Receptors, GABA-A | 5 | 2020 | 65 | 0.630 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 58 | 0.590 |
Why?
|
| Altitude Sickness | 1 | 2018 | 3 | 0.580 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2024 | 1766 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 16 | 2026 | 1869 | 0.580 |
Why?
|
| Atherosclerosis | 3 | 2026 | 169 | 0.540 |
Why?
|
| Uterus | 1 | 2017 | 52 | 0.540 |
Why?
|
| Flavonols | 5 | 2022 | 19 | 0.530 |
Why?
|
| Heart Diseases | 1 | 2018 | 112 | 0.520 |
Why?
|
| Drug Delivery Systems | 3 | 2018 | 277 | 0.510 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 236 | 0.480 |
Why?
|
| Rats | 17 | 2024 | 3735 | 0.470 |
Why?
|
| Pregnancy | 11 | 2024 | 1772 | 0.460 |
Why?
|
| Mice | 18 | 2026 | 6644 | 0.410 |
Why?
|
| Patch-Clamp Techniques | 3 | 2012 | 228 | 0.390 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 92 | 0.390 |
Why?
|
| Respiratory Mechanics | 2 | 2003 | 27 | 0.380 |
Why?
|
| Animals, Newborn | 5 | 2024 | 352 | 0.360 |
Why?
|
| Disease Models, Animal | 8 | 2026 | 1596 | 0.360 |
Why?
|
| Medulla Oblongata | 2 | 2020 | 42 | 0.350 |
Why?
|
| Autophagy | 3 | 2021 | 140 | 0.340 |
Why?
|
| DNA Methylation | 3 | 2024 | 403 | 0.340 |
Why?
|
| Cotinine | 3 | 2020 | 44 | 0.340 |
Why?
|
| Heart | 3 | 2020 | 184 | 0.330 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 388 | 0.330 |
Why?
|
| Protein Subunits | 3 | 2017 | 93 | 0.320 |
Why?
|
| Arenaria Plant | 2 | 2020 | 2 | 0.320 |
Why?
|
| Male | 23 | 2025 | 23409 | 0.300 |
Why?
|
| CpG Islands | 3 | 2024 | 109 | 0.300 |
Why?
|
| Flavonoids | 2 | 2020 | 100 | 0.290 |
Why?
|
| Anion Transport Proteins | 2 | 2019 | 3 | 0.290 |
Why?
|
| Ion Transport | 2 | 2019 | 23 | 0.280 |
Why?
|
| Smoking | 4 | 2020 | 1024 | 0.280 |
Why?
|
| Antiporters | 2 | 2019 | 14 | 0.280 |
Why?
|
| Hypertension | 2 | 2025 | 835 | 0.260 |
Why?
|
| Neurochemistry | 1 | 2006 | 6 | 0.260 |
Why?
|
| Maternal Exposure | 3 | 2024 | 57 | 0.250 |
Why?
|
| Nicotinic Antagonists | 3 | 2017 | 36 | 0.250 |
Why?
|
| Neurons | 4 | 2012 | 1263 | 0.250 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2026 | 2 | 0.250 |
Why?
|
| Biological Assay | 1 | 2006 | 63 | 0.250 |
Why?
|
| Electrodes | 1 | 2006 | 59 | 0.250 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 69 | 0.250 |
Why?
|
| Physical Conditioning, Animal | 1 | 2026 | 33 | 0.240 |
Why?
|
| Calcinosis | 1 | 2026 | 62 | 0.230 |
Why?
|
| Central Nervous System | 1 | 2006 | 152 | 0.230 |
Why?
|
| Ventricular Remodeling | 1 | 2026 | 61 | 0.230 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2025 | 15 | 0.230 |
Why?
|
| Hyperlipidemias | 1 | 2025 | 48 | 0.230 |
Why?
|
| Social Isolation | 2 | 2022 | 34 | 0.230 |
Why?
|
| Brain | 2 | 2024 | 1472 | 0.220 |
Why?
|
| Blood Pressure | 2 | 2025 | 666 | 0.220 |
Why?
|
| Receptors, Angiotensin | 1 | 2024 | 13 | 0.220 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 126 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 465 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 83 | 0.210 |
Why?
|
| Female | 14 | 2026 | 24698 | 0.200 |
Why?
|
| Heart Rate | 1 | 2024 | 266 | 0.200 |
Why?
|
| Ethanol | 2 | 2017 | 224 | 0.200 |
Why?
|
| Inhalation | 1 | 2003 | 8 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2025 | 114 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 316 | 0.200 |
Why?
|
| Receptors, AMPA | 1 | 2003 | 58 | 0.190 |
Why?
|
| Kidney | 1 | 2025 | 372 | 0.190 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 74 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 96 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2024 | 2157 | 0.180 |
Why?
|
| Myocardium | 2 | 2020 | 263 | 0.170 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 183 | 0.170 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 44 | 0.170 |
Why?
|
| Geraniaceae | 1 | 2020 | 1 | 0.170 |
Why?
|
| Biological Clocks | 2 | 2019 | 52 | 0.170 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 19 | 0.170 |
Why?
|
| Mice, Transgenic | 4 | 2026 | 665 | 0.170 |
Why?
|
| Mice, Obese | 1 | 2020 | 42 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2022 | 140 | 0.160 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2008 | 80 | 0.160 |
Why?
|
| Buffers | 1 | 2020 | 17 | 0.160 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2020 | 2 | 0.160 |
Why?
|
| Plant Extracts | 2 | 2020 | 302 | 0.160 |
Why?
|
| Astrocytes | 1 | 2022 | 244 | 0.160 |
Why?
|
| Adenine | 1 | 2020 | 46 | 0.160 |
Why?
|
| Hippocampus | 3 | 2022 | 594 | 0.160 |
Why?
|
| Ammonia | 1 | 2019 | 22 | 0.160 |
Why?
|
| Microglia | 1 | 2022 | 208 | 0.150 |
Why?
|
| Amygdala | 1 | 2020 | 125 | 0.150 |
Why?
|
| Membrane Potentials | 3 | 2012 | 222 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 532 | 0.150 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2018 | 3 | 0.150 |
Why?
|
| Asteraceae | 1 | 2018 | 4 | 0.150 |
Why?
|
| Fetal Heart | 1 | 2018 | 4 | 0.150 |
Why?
|
| Altitude | 1 | 2018 | 10 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 291 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2018 | 40 | 0.140 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 138 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2019 | 122 | 0.140 |
Why?
|
| Models, Animal | 1 | 2018 | 151 | 0.140 |
Why?
|
| Mecamylamine | 1 | 2017 | 21 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 53 | 0.140 |
Why?
|
| Humans | 11 | 2023 | 43102 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 252 | 0.130 |
Why?
|
| Obesity | 1 | 2025 | 1151 | 0.130 |
Why?
|
| Ovary | 1 | 2017 | 113 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 386 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1035 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2017 | 536 | 0.110 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2020 | 518 | 0.110 |
Why?
|
| Synaptic Potentials | 1 | 2014 | 8 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 12 | 0.110 |
Why?
|
| Oxidative Stress | 4 | 2020 | 1003 | 0.100 |
Why?
|
| Anxiety | 3 | 2022 | 874 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2016 | 430 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2014 | 77 | 0.100 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 100 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2025 | 68 | 0.100 |
Why?
|
| Lethal Dose 50 | 1 | 2012 | 32 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 28 | 0.100 |
Why?
|
| Apoptosis | 1 | 2020 | 1568 | 0.100 |
Why?
|
| Synaptic Transmission | 2 | 2019 | 149 | 0.100 |
Why?
|
| Equipment Design | 1 | 2012 | 145 | 0.090 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 16 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2012 | 138 | 0.090 |
Why?
|
| Alcoholic Intoxication | 1 | 2012 | 21 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 19 | 0.090 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 48 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 101 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 78 | 0.090 |
Why?
|
| Periodicity | 2 | 2008 | 34 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2024 | 216 | 0.080 |
Why?
|
| Inhalation Exposure | 2 | 2021 | 44 | 0.080 |
Why?
|
| Alcoholism | 1 | 2014 | 305 | 0.080 |
Why?
|
| Medicine, Tibetan Traditional | 2 | 2020 | 2 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 7 | 0.080 |
Why?
|
| Echocardiography | 2 | 2020 | 167 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1124 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2009 | 27 | 0.070 |
Why?
|
| Phenotype | 2 | 2023 | 780 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 526 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 1 | 2008 | 6 | 0.070 |
Why?
|
| Apnea | 1 | 2008 | 8 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2009 | 131 | 0.070 |
Why?
|
| Somatostatin | 1 | 2008 | 20 | 0.070 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2008 | 4 | 0.070 |
Why?
|
| Xenopus laevis | 1 | 2008 | 73 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2020 | 570 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 150 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 93 | 0.070 |
Why?
|
| Oocytes | 1 | 2008 | 149 | 0.070 |
Why?
|
| Microelectrodes | 1 | 2006 | 22 | 0.060 |
Why?
|
| Syringes | 1 | 2006 | 7 | 0.060 |
Why?
|
| Neurophysiology | 1 | 2006 | 10 | 0.060 |
Why?
|
| Electric Capacitance | 1 | 2006 | 7 | 0.060 |
Why?
|
| Bicarbonates | 2 | 2019 | 13 | 0.060 |
Why?
|
| Agar | 1 | 2006 | 9 | 0.060 |
Why?
|
| Potassium Chloride | 1 | 2006 | 24 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2006 | 28 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.060 |
Why?
|
| Diffusion | 1 | 2006 | 63 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2006 | 77 | 0.060 |
Why?
|
| Brain Stem | 1 | 2006 | 52 | 0.060 |
Why?
|
| Chlorides | 1 | 2006 | 59 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 1001 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 188 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2009 | 972 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 125 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 73 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 114 | 0.060 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2025 | 6 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 107 | 0.060 |
Why?
|
| Aorta | 1 | 2026 | 198 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 246 | 0.060 |
Why?
|
| Energy Intake | 1 | 2025 | 164 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2006 | 176 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2006 | 408 | 0.050 |
Why?
|
| Lipolysis | 1 | 2023 | 20 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2024 | 185 | 0.050 |
Why?
|
| Pyrazines | 1 | 2023 | 32 | 0.050 |
Why?
|
| Superoxides | 1 | 2023 | 57 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 386 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 491 | 0.050 |
Why?
|
| Algorithms | 1 | 2006 | 509 | 0.050 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2003 | 10 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2003 | 55 | 0.050 |
Why?
|
| Hypoglossal Nerve | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mutation | 2 | 2019 | 1177 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 299 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 1028 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 492 | 0.040 |
Why?
|
| Maze Learning | 1 | 2022 | 113 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 34 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2006 | 735 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2020 | 12 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 95 | 0.040 |
Why?
|
| Gestational Age | 1 | 2021 | 200 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 41 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 78 | 0.040 |
Why?
|
| Fetal Development | 1 | 2020 | 34 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 329 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 160 | 0.040 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2019 | 13 | 0.040 |
Why?
|
| Time Factors | 1 | 2024 | 1857 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2016 | 403 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 157 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1175 | 0.040 |
Why?
|
| Age Factors | 2 | 2014 | 1154 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 678 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2020 | 123 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2019 | 52 | 0.040 |
Why?
|
| Sodium | 1 | 2019 | 102 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 388 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2019 | 90 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 506 | 0.040 |
Why?
|
| Flunitrazepam | 1 | 2018 | 2 | 0.040 |
Why?
|
| Pentylenetetrazole | 1 | 2018 | 7 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 150 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 300 | 0.040 |
Why?
|
| Motor Activity | 1 | 2020 | 437 | 0.030 |
Why?
|
| China | 1 | 2018 | 229 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 191 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1082 | 0.030 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2016 | 4 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2016 | 8 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 10 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1600 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2016 | 561 | 0.020 |
Why?
|
| Gramicidin | 1 | 2012 | 2 | 0.020 |
Why?
|
| Equipment Reuse | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 18 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2014 | 243 | 0.020 |
Why?
|
| CHO Cells | 1 | 2012 | 123 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 64 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 241 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 204 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 3994 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Dependovirus | 1 | 2008 | 18 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2008 | 12 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 432 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 25 | 0.020 |
Why?
|
| Wakefulness | 1 | 2008 | 24 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 48 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2008 | 64 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 165 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 209 | 0.020 |
Why?
|
| Drosophila | 1 | 2008 | 152 | 0.020 |
Why?
|
| Nerve Net | 1 | 2008 | 101 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 532 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 31 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 83 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2006 | 91 | 0.010 |
Why?
|
| Spleen | 1 | 2006 | 204 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 249 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 462 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 456 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 12222 | 0.010 |
Why?
|